X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3129) 3129
Publication (164) 164
Newsletter (92) 92
Book Chapter (11) 11
Book Review (8) 8
Book / eBook (2) 2
Dissertation (2) 2
Government Document (2) 2
Conference Proceeding (1) 1
Data Set (1) 1
Magazine Article (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
ascites (1809) 1809
humans (1777) 1777
female (1346) 1346
index medicus (1206) 1206
animals (1180) 1180
male (966) 966
mice (814) 814
middle aged (710) 710
oncology (578) 578
immunology (573) 573
adult (548) 548
aged (507) 507
ascites - immunology (448) 448
cancer (443) 443
gastroenterology & hepatology (372) 372
cirrhosis (358) 358
liver (337) 337
liver cirrhosis (336) 336
research (325) 325
patients (301) 301
ovarian cancer (293) 293
ascites - etiology (285) 285
tumors (269) 269
surgery (259) 259
analysis (255) 255
medicine (244) 244
mortality (244) 244
research article (244) 244
diagnosis (239) 239
prognosis (234) 234
survival (234) 234
care and treatment (233) 233
multidisciplinary sciences (230) 230
ascites - pathology (228) 228
expression (226) 226
liver diseases (212) 212
rats (208) 208
health aspects (204) 204
risk factors (200) 200
transplantation (198) 198
science (193) 193
ovarian neoplasms - immunology (192) 192
carcinoma (190) 190
ovarian neoplasms - pathology (190) 190
cell biology (187) 187
malignant ascites (186) 186
treatment outcome (183) 183
management (182) 182
antibodies (178) 178
mice, inbred balb c (176) 176
proteins (174) 174
retrospective studies (171) 171
medical research (170) 170
immunotherapy (166) 166
aged, 80 and over (164) 164
liver cirrhosis - complications (164) 164
cell line, tumor (162) 162
chemotherapy (161) 161
cells (155) 155
neoplasm transplantation (155) 155
metastasis (148) 148
medicine & public health (145) 145
peritonitis (141) 141
therapy (140) 140
antigens (139) 139
cytokines (138) 138
lymphocytes (135) 135
biochemistry & molecular biology (133) 133
medical prognosis (132) 132
ascites - metabolism (131) 131
time factors (130) 130
neoplasms - immunology (129) 129
flow cytometry (126) 126
tumor cells, cultured (126) 126
hypertension (125) 125
disease (122) 122
apoptosis (120) 120
infections (120) 120
medicine and health sciences (120) 120
antibodies, monoclonal - immunology (119) 119
liver transplantation (119) 119
gene expression (118) 118
pathology (118) 118
enzyme-linked immunosorbent assay (117) 117
gastroenterology (116) 116
infectious diseases (116) 116
inflammation (116) 116
medicine, experimental (116) 116
gastroenterology and hepatology (115) 115
monoclonal antibodies (115) 115
hepatology (114) 114
medicine, research & experimental (113) 113
pharmacology & pharmacy (111) 111
ovarian carcinoma (110) 110
peritoneum (109) 109
biology and life sciences (107) 107
macrophages (106) 106
microbiology (103) 103
ascites - drug therapy (100) 100
studies (99) 99
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3113) 3113
Chinese (23) 23
German (23) 23
Japanese (19) 19
Russian (19) 19
French (16) 16
Spanish (9) 9
Italian (5) 5
Polish (4) 4
Czech (3) 3
Hungarian (1) 1
Korean (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Acta Tropica, ISSN 0001-706X, 09/2015, Volume 149, pp. 138 - 147
Journal Article
Immunity, ISSN 1074-7613, 09/2017, Volume 47, Issue 3, pp. 582 - 596.e6
After entering tissues, monocytes differentiate into cells that share functional features with either macrophages or dendritic cells (DCs). How monocyte fate... 
MAFB | IRF4 | monocyte | macrophage | human | dendritic cell | aryl hydrocarbon receptor | TISSUE-RESIDENT | POPULATION | GENE | PROGRAMS | MOUSE | LY6C(HI) MONOCYTES | IMMUNOLOGY | IDENTIFICATION | EXPRESSION | REVEALS | BALANCE | Neoplasms - metabolism | MafB Transcription Factor - metabolism | Leprosy - microbiology | Monocytes - cytology | Dendritic Cells - immunology | Humans | Interferon Regulatory Factors - metabolism | Transcriptome | Male | Monocytes - metabolism | Gene Expression Profiling | Monocytes - immunology | Neoplasms - genetics | Receptors, Aryl Hydrocarbon - metabolism | Dendritic Cells - drug effects | Female | Dendritic Cells - metabolism | Macrophages - immunology | Repressor Proteins - metabolism | Cytokines - metabolism | Cells, Cultured | Gene Expression Regulation | Leprosy - metabolism | Receptors, Aryl Hydrocarbon - genetics | Leprosy - immunology | Macrophages - cytology | Mice, Knockout | Monocytes - drug effects | Macrophages - metabolism | Animals | Macrophages - drug effects | Dendritic Cells - cytology | Mice | Ascites | Cytokines - pharmacology | Cluster Analysis | Positive Regulatory Domain I-Binding Factor 1 | Leprosy | Dendritic cells | Macrophages | Analysis | DNA binding proteins | Molecular machines | Regulators | Transcription factors | Cytokines | Hydrocarbons | Activation | Inflammation | Environmental factors | Gene expression | Tissues | Monocytes | Cell activation | Aromatic compounds | Interferon regulatory factor 4 | Infiltration | Lesions | Differentiation | Life Sciences | Innate immunity | Immunology | Adaptive immunology
Journal Article
Cancer Research, ISSN 0008-5472, 10/2010, Volume 70, Issue 19, pp. 7476 - 7488
Journal Article
Cancer Immunology, Immunotherapy, ISSN 0340-7004, 10/2006, Volume 55, Issue 10, pp. 1185 - 1197
Although melanoma tumors usually express antigens that can be recognized by T cells, immune-mediated tumor rejection is rare. In many cases this is despite the... 
Biomedicine | Immunology | Tumor immunity | Cytotoxic T cells | Tolerance | Oncology | Cancer Research | Cell differentiation | cell differentiation | INDOLEAMINE 2,3-DIOXYGENASE | tumor immunity | PERIPHERAL-BLOOD | INDUCTION | IMMUNOLOGY | CANCER | METASTATIC MELANOMA | RESPONSES | ONCOLOGY | IMMUNOTHERAPY | CLASS-I | cytotoxic T cells | EXPRESSION | tolerance | LYMPHOCYTES | Antigens, Differentiation - therapeutic use | T-Lymphocyte Subsets - immunology | Melanoma - complications | Tumor Escape | Humans | Immunosuppressive Agents - therapeutic use | Interleukin-2 - therapeutic use | Male | Antineoplastic Agents - therapeutic use | gp100 Melanoma Antigen | Lymphocyte Activation - immunology | Flow Cytometry | Interleukin-2 - immunology | Cancer Vaccines | Immunotherapy | Ascites - immunology | Adult | Membrane Glycoproteins - immunology | Ascitic Fluid - cytology | Chemokines - immunology | Ascitic Fluid - immunology | Ascites - etiology | Ascitic Fluid - chemistry | Antigens, Neoplasm - immunology | Antineoplastic Agents - immunology | Antigen Presentation - immunology | Reverse Transcriptase Polymerase Chain Reaction | CTLA-4 Antigen | Histocompatibility Antigens Class II - immunology | Membrane Glycoproteins - therapeutic use | Immunosuppressive Agents - immunology | Melanoma - immunology | CD8-Positive T-Lymphocytes - immunology | Melanoma - therapy | Antigens, CD | Antigens, Differentiation - immunology
Journal Article
Journal Article
Anticancer Research, ISSN 0250-7005, 08/2009, Volume 29, Issue 8, pp. 2875 - 2884
Background: To identify immunosuppressive elements present in ovarian cancer associated ascites. Patients and Methods: Ascites and plasma were obtained from... 
Cell mediated immunity | Cytokines | Ascites | Chemokines | Ovarian cancer | DENDRITIC CELLS | PANCREATIC-CANCER | PERIPHERAL-BLOOD | chemokines | CYTOTOXIC T-LYMPHOCYTES | TUMOR-INFILTRATING LYMPHOCYTES | ascites | ADOPTIVE TRANSFER | ONCOLOGY | IN-VIVO | cytokines | cell mediated immunity | ANTIGEN-PRESENTING CELLS | PROGNOSTIC-SIGNIFICANCE | ENDOTHELIAL GROWTH-FACTOR | CD8-Positive T-Lymphocytes - pathology | Prognosis | Humans | Middle Aged | Cystadenocarcinoma, Serous - metabolism | Endometrial Neoplasms - metabolism | Ovarian Neoplasms - pathology | CD4-Positive T-Lymphocytes - pathology | Adenocarcinoma, Clear Cell - immunology | T-Lymphocytes, Regulatory - immunology | CD4-Positive T-Lymphocytes - immunology | Antigen-Presenting Cells - pathology | Endometrial Neoplasms - immunology | Flow Cytometry | Fallopian Tube Neoplasms - immunology | Aged, 80 and over | Ascites - immunology | CD8-Positive T-Lymphocytes - metabolism | Adult | Female | Ovarian Neoplasms - metabolism | Cystadenocarcinoma, Serous - immunology | Peritoneal Neoplasms - immunology | Peritoneal Neoplasms - pathology | Cystadenocarcinoma, Serous - secondary | Antigen-Presenting Cells - metabolism | Cytokines - metabolism | Adenocarcinoma, Clear Cell - metabolism | CD4-Positive T-Lymphocytes - metabolism | Fallopian Tube Neoplasms - pathology | Survival Rate | Chromium - metabolism | Antigen-Presenting Cells - immunology | Endometrial Neoplasms - secondary | Adenocarcinoma, Clear Cell - secondary | Ascites - metabolism | Peritoneal Neoplasms - metabolism | Aged | Fallopian Tube Neoplasms - metabolism | CD8-Positive T-Lymphocytes - immunology | Ascites - pathology | Ovarian Neoplasms - immunology
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2012, Volume 7, Issue 10, p. e47190
Background: The regulatory T cells (Tregs) can actively suppress the immune responses. However, literature about detailed changes of host effective and... 
TGF-BETA | IMMUNOTHERAPY | IFN-GAMMA | MULTIDISCIPLINARY SCIENCES | OVARIAN-CANCER | PROGNOSTIC-SIGNIFICANCE | RNA VACCINE POTENCY | CARCINOMA | ESCAPE | CHEMOTHERAPY | IMMUNOLOGICAL RESPONSES | Dose-Response Relationship, Immunologic | Spleen - immunology | Humans | Ovarian Neoplasms - pathology | Lymphocyte Depletion | T-Lymphocytes, Regulatory - immunology | Lymphocyte Activation - immunology | Ascites - immunology | Female | Spleen - pathology | Antibodies, Monoclonal - immunology | Interleukin-2 Receptor alpha Subunit - immunology | Antibodies, Neoplasm - immunology | Cytokines - metabolism | Antigens, Neoplasm - immunology | Mice, Inbred C57BL | Immunity - immunology | Disease Progression | Tumor Microenvironment - immunology | Animals | Antibodies, Monoclonal - administration & dosage | Cell Line, Tumor | Mice | Kinetics | CD8-Positive T-Lymphocytes - immunology | Neoplasm Staging | Ovarian Neoplasms - immunology | Usage | Immune response | Carcinoma | Immunotherapy | Research | T cells | Ovarian cancer | Cancer | Flow cytometry | Ovarian carcinoma | CD8 antigen | Oncology | Lymphocytes T | Cancer therapies | Anticancer properties | Interleukin 6 | Interleukin 4 | Clonal deletion | Lymphocytes | Deletion | CD25 antigen | Enzyme-linked immunosorbent assay | Antigens | Cytokines | Immunoregulation | Gynecology | Tumor necrosis factor-α | Patients | Obstetrics | Polymerase chain reaction | Medicine | Survival analysis | Chemotherapy | Depletion | Medical prognosis | γ-Interferon | Interleukin 10 | Monoclonal antibodies | Interferon | Laboratory animals | Ascites | Peritoneum | Tumors
Journal Article
International Journal of Cancer, ISSN 0020-7136, 01/2014, Volume 134, Issue 1, pp. 32 - 42
Ovarian cancer is typically accompanied by the occurrence of malignant ascites containing large number of macrophages. It has been suggested that these... 
ovarian carcinoma | CD163 | tumor‐associated macrophages | IL‐10 | IL‐6 | IL-10 | IL-6 | tumor-associated macrophages | MYELOID CELLS | INTERLEUKIN-6 | M2-POLARIZED MACROPHAGES | HUMAN MONOCYTES | CANCER | SCAVENGER RECEPTOR CD163 | ONCOLOGY | SERUM-LEVELS | IN-VIVO | PROGNOSTIC-SIGNIFICANCE | Antigens, CD - immunology | Cell Polarity | Oligonucleotide Array Sequence Analysis | Antigens, CD - biosynthesis | Humans | Cystadenocarcinoma, Serous - metabolism | Ovarian Neoplasms - pathology | Transcriptome | Cystadenocarcinoma, Serous - pathology | Neoplasm Recurrence, Local - immunology | Neoplasm Recurrence, Local - pathology | Flow Cytometry | Ascites - immunology | Female | Ovarian Neoplasms - metabolism | Receptors, Cell Surface - biosynthesis | Cystadenocarcinoma, Serous - immunology | Antigens, Differentiation, Myelomonocytic - immunology | Macrophages - immunology | Cytokines - immunology | Antigens, Differentiation, Myelomonocytic - biosynthesis | Enzyme-Linked Immunosorbent Assay | Macrophages - pathology | Neoplasm Recurrence, Local - metabolism | Kaplan-Meier Estimate | Receptors, Cell Surface - immunology | Disease-Free Survival | Macrophages - metabolism | Phenotype | Cytokines - biosynthesis | Ovarian Neoplasms - immunology | Carcinoma | Cytokines | Analysis | Genetic aspects | Macrophages | Gene expression | Ascites | Ovarian cancer | Cancer | Genotype & phenotype | Cancer Cell Biology
Journal Article
Journal Article
Journal Article